@dansfera: Wait, is this the secret signal for a cheap biotech stock? 🤯 Discover the crucial comparison: Risk-Adjusted Net Present Value versus the company's actual Enterprise Value (that includes all the debt and cash!). If your calculated NPV towers over the EV, that's a major red flag that the market might be sleeping on this gem. Commercial biotech investors, make sure you're also checking that EV/Revenue multiple! 💰💡 #BiotechInvesting #StockMarketTips #ValueInvesting #FinancialEducation #StockTok